Published in BMJ Open on February 17, 2014
Tracking Resistance to Artemisinin (TRAC) (TRAC) | NCT01350856
ICH harmonized tripartite guideline: Guideline for Good Clinical Practice. J Postgrad Med (2001) 6.16
The Good Clinical Practice guideline: a bronze standard for clinical research. Lancet (2005) 2.81
Specific barriers to the conduct of randomized trials. Clin Trials (2008) 2.68
Ensuring trial validity by data quality assurance and diversification of monitoring methods. Clin Trials (2008) 2.50
Sensible approaches for reducing clinical trial costs. Clin Trials (2008) 2.20
The unintended consequences of clinical trials regulations. PLoS Med (2009) 1.91
Clinical trials have gone global: is this a good thing? PLoS Med (2012) 1.58
Clinical research: time for sensible global guidelines. Lancet (2011) 1.29
A statistical approach to central monitoring of data quality in clinical trials. Clin Trials (2012) 1.17
Sensible guidelines for the conduct of large randomized trials. Clin Trials (2008) 1.07
A Peer Review Intervention for Monitoring and Evaluating sites (PRIME) that improved randomized controlled trial conduct and performance. J Clin Epidemiol (2011) 0.95
A systematic review of on-site monitoring methods for health-care randomised controlled trials. Clin Trials (2013) 0.89
The elephant in the (board) room: the role of contract research organizations in international clinical research. Am J Bioeth (2012) 0.82
The B73 maize genome: complexity, diversity, and dynamics. Science (2009) 18.73
Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med (2014) 11.87
Mortality after fluid bolus in African children with severe infection. N Engl J Med (2011) 10.99
Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet (2006) 10.91
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N Engl J Med (2011) 10.79
Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet (2010) 8.52
Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age. N Engl J Med (2008) 7.28
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med (2012) 6.64
A major genome region underlying artemisinin resistance in malaria. Science (2012) 6.25
Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator. Malar J (2011) 5.65
Short-course antiretroviral therapy in primary HIV infection. N Engl J Med (2013) 4.82
Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat Genet (2009) 4.30
In vivo parasitological measures of artemisinin susceptibility. J Infect Dis (2010) 4.25
The threat of artemisinin-resistant malaria. N Engl J Med (2011) 4.15
Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet (2007) 3.93
Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison. Lancet (2006) 3.90
Disclosure of individual genetic data to research participants: the debate reconsidered. Trends Genet (2010) 3.83
Effectiveness of mass oral cholera vaccination in Beira, Mozambique. N Engl J Med (2005) 3.68
The dynamics of measles in sub-Saharan Africa. Nature (2008) 3.35
Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial. Lancet Infect Dis (2010) 3.08
Research capacity. Enabling the genomic revolution in Africa. Science (2014) 3.05
Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet (2013) 2.92
Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial. Lancet Infect Dis (2011) 2.79
Clinical research in resource-limited settings: enhancing research capacity and working together to make trials less complicated. PLoS Negl Trop Dis (2010) 2.68
Zanamivir-resistant influenza viruses with a novel neuraminidase mutation. J Virol (2009) 2.59
Role of next of kin in accessing health records of deceased relatives. BMJ (2004) 2.48
Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational study. PLoS Med (2013) 2.46
Operational response to malaria epidemics: are rapid diagnostic tests cost-effective? Trop Med Int Health (2006) 2.39
CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa. PLoS One (2009) 2.37
A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya. PLoS Clin Trials (2006) 2.33
Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial. Lancet Infect Dis (2010) 2.24
Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure. N Engl J Med (2013) 2.24
Valid consent for genomic epidemiology in developing countries. PLoS Med (2007) 2.14
Population genetic correlates of declining transmission in a human pathogen. Mol Ecol (2012) 2.09
Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004. Lancet Infect Dis (2005) 2.06
Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa. J Infect Dis (2008) 2.05
Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa. AIDS Res Hum Retroviruses (2010) 2.05
Ethical issues in human genomics research in developing countries. BMC Med Ethics (2011) 2.02
The primacy of public health considerations in defining poor quality medicines. PLoS Med (2011) 1.91
Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa. Vaccine (2008) 1.89
Mind the gaps--the epidemiology of poor-quality anti-malarials in the malarious world--analysis of the WorldWide Antimalarial Resistance Network database. Malar J (2014) 1.86
Evaluation of three parasite lactate dehydrogenase-based rapid diagnostic tests for the diagnosis of falciparum and vivax malaria. Malar J (2009) 1.86
Sequencing, mapping, and analysis of 27,455 maize full-length cDNAs. PLoS Genet (2009) 1.83
Confidentiality and serious harm in genetics - preserving the confidentiality of one patient and preventing harm to relatives. Eur J Hum Genet (2004) 1.77
Poor quality vital anti-malarials in Africa - an urgent neglected public health priority. Malar J (2011) 1.76
HIV and syphilis prevalence and associated risk factors among fishing communities of Lake Victoria, Uganda. Sex Transm Infect (2011) 1.75
Meningitis serogroup W135 outbreak, Burkina Faso, 2002. Emerg Infect Dis (2007) 1.75
Chikungunya virus strains, Reunion Island outbreak. Emerg Infect Dis (2006) 1.73
Concordant proficiency in measurement of T-cell immunity in human immunodeficiency virus vaccine clinical trials by peripheral blood mononuclear cell and enzyme-linked immunospot assays in laboratories from three continents. Clin Vaccine Immunol (2008) 1.71
HIV type 1 subtype distribution, multiple infections, sexual networks, and partnership histories in female sex workers in Kampala, Uganda. AIDS Res Hum Retroviruses (2011) 1.63
High HIV incidence and socio-behavioral risk patterns in fishing communities on the shores of Lake Victoria, Uganda. Sex Transm Dis (2012) 1.62
Should clinicians incorporate positive spirituality into their practices? What does the evidence say? Ann Behav Med (2002) 1.60
Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis. Int J Epidemiol (2013) 1.57
Mapping the aetiology of non-malarial febrile illness in Southeast Asia through a systematic review--terra incognita impairing treatment policies. PLoS One (2012) 1.56
World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs. Malar J (2007) 1.56
Data sharing and intellectual property in a genomic epidemiology network: policies for large-scale research collaboration. Bull World Health Organ (2006) 1.56
Seeking consent to genetic and genomic research in a rural Ghanaian setting: a qualitative study of the MalariaGEN experience. BMC Med Ethics (2012) 1.55
Late vaccination reinforcement during a measles epidemic in Niamey, Niger (2003-2004). Vaccine (2006) 1.53
Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems. Lancet Infect Dis (2012) 1.53
Epidemiology of prostatitis. Int J Antimicrob Agents (2007) 1.53
Impact of an informed choice invitation on uptake of screening for diabetes in primary care (DICISION): randomised trial. BMJ (2010) 1.52
Laparoscopic surgery performed through a single incision: a systematic review of the current literature. J Am Coll Surg (2010) 1.49
Open source clinical science for emerging infections. Lancet Infect Dis (2014) 1.47
Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1. J Virol Methods (2009) 1.46
A case-control auditory evaluation of patients treated with artemether-lumefantrine. Am J Trop Med Hyg (2006) 1.45
Phase II trial on the use of Dextran 70 or starch for supportive therapy in Kenyan children with severe malaria. Crit Care Med (2010) 1.45
Transmitted antiretroviral drug resistance among newly HIV-1 diagnosed young individuals in Kampala. AIDS (2011) 1.44
Predicting the clinical outcome of severe falciparum malaria in african children: findings from a large randomized trial. Clin Infect Dis (2012) 1.39
A prospective, in vivo evaluation of two pressure-redistribution surfaces in healthy volunteers using pressure mapping as a quality control instrument . Ostomy Wound Manage (2013) 1.39
The induction and persistence of T cell IFN-gamma responses after vaccination or natural exposure is suppressed by Plasmodium falciparum. J Immunol (2007) 1.38
Bleach sedimentation: an opportunity to optimize smear microscopy for tuberculosis diagnosis in settings of high prevalence of HIV. Clin Infect Dis (2008) 1.38
Use of deferred consent for severely ill children in a multi-centre phase III trial. Trials (2011) 1.36
Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between zidovudine-lamivudine plus Nevirapine and zidovudine-lamivudine plus Abacavir. J Infect Dis (2010) 1.36
Excess child mortality after discharge from hospital in Kilifi, Kenya: a retrospective cohort analysis. Bull World Health Organ (2011) 1.34
Practical guidelines addressing ethical issues pertaining to the curation of human locus-specific variation databases (LSDBs). Hum Mutat (2010) 1.33
Equivalence of ELISpot assays demonstrated between major HIV network laboratories. PLoS One (2010) 1.30
Clinical research: time for sensible global guidelines. Lancet (2011) 1.29
Feasibility and effectiveness of cotrimoxazole prophylaxis for HIV-1-infected adults attending an HIV/AIDS clinic in Uganda. J Acquir Immune Defic Syndr (2006) 1.29
The relationship between the haemoglobin concentration and the haematocrit in Plasmodium falciparum malaria. Malar J (2008) 1.29
Effect of the pre-erythrocytic candidate malaria vaccine RTS,S/AS01E on blood stage immunity in young children. J Infect Dis (2011) 1.28
High HIV-1 prevalence, risk behaviours, and willingness to participate in HIV vaccine trials in fishing communities on Lake Victoria, Uganda. J Int AIDS Soc (2013) 1.28
Community engagement on the Thai-Burmese border: rationale, experience and lessons learnt. Int Health (2010) 1.28
A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine. Vaccine (2011) 1.25
Safety profile of the viral vectors of attenuated fowlpox strain FP9 and modified vaccinia virus Ankara recombinant for either of 2 preerythrocytic malaria antigens, ME-TRAP or the circumsporozoite protein, in children and adults in Kenya. Clin Infect Dis (2006) 1.25
Epidemiology of prostatitis: new evidence for a world-wide problem. World J Urol (2003) 1.24
Research in complex humanitarian emergencies: the Médecins Sans Frontières/Epicentre experience. PLoS Med (2008) 1.20
Low-level malaria infections detected by a sensitive polymerase chain reaction assay and use of this technique in the evaluation of malaria vaccines in an endemic area. Am J Trop Med Hyg (2007) 1.20